ExodusPoint Capital Management »

Rigel Pharmaceuticals shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $464k 16k 28.33
2024-12-31 $260k 16k 16.79

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ameren Corporation (AEE)
Merck & Co Call Option (MRK)
Nebius Group Shs Class A Put Option (NBIS)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Evergy (EVRG)
Microsoft Corporation Put Option (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Rigel Pharmaceuticals

BlackRock
Morgan Stanley
Vanguard Group
Goldman Sachs Group
Armistice Capital
Acadian Asset Management
Marshall Wace
Capitolis Liquid Global Markets
State Street Corporation
Renaissance Technologies
Geode Capital Management
Qube Research & Technologies
Jane Street
Soleus Capital Management
D. E. Shaw & Co

View all funds holding Rigel Pharmaceuticals